IP Verse

Composition For The Treatment Of Polycystic Ovary Syndrome - EP3448370

The patent EP3448370 was granted to Sochim on Jul 12, 2023. The application was originally filed on Apr 27, 2017 under application number EP17730926A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP3448370

SOCHIM
Application Number
EP17730926A
Filing Date
Apr 27, 2017
Status
Patent Maintained As Amended
Jun 9, 2023
Publication Date
Jul 12, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

LOLI PHARMAJul 21, 2021CAPASSOADMISSIBLE

Patent Citations (17) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTEP3165229
INTERNATIONAL-SEARCH-REPORTWO2013016741
INTERNATIONAL-SEARCH-REPORTWO2013016742
OPPOSITIONEP2502622
OPPOSITIONEP2875809
OPPOSITIONEP2923701
OPPOSITIONEP3165229
OPPOSITIONJP2006213684
OPPOSITIONUS2009263505
OPPOSITIONUS2010119498
OPPOSITIONUS5906979
OPPOSITIONWO2006069385
OPPOSITIONWO2012080831
OPPOSITIONWO2013016741
OPPOSITIONWO2013016742
OPPOSITIONWO2014096209
OPPOSITIONWO2016015634

Non-Patent Literature (NPL) Citations (5) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
INTERNATIONAL-SEARCH-REPORT- Anonymous, "AntaGolin combats insulin resistance through multiple pathways of action", (20170103), URL: http://mnilifestyle.co.za/products/antagolin/, (20170103), XP055331782 [T] 1-12 * the whole document *
INTERNATIONAL-SEARCH-REPORT- Anonymous, "Combining science and nature AntaGolin... - Insulin resistance, raising awareness through our journey | Facebook", (20131115), URL: https://www.facebook.com/InsulinResistanceRaisingAwarenessThroughOurJourney/posts/334934786647039, (20170103), XP055331781 [X] 1,6,7,9,10,12 * the whole document * [I] 1-12
OPPOSITION- D. KARTOLO et al., "Clinical experience with DLBS3233, a combination of cinnamommum burmannii and lagerstroemia speciosa, for polycystic ovary syndrome treatment", Asian Journal of Pharmaceutical and Clinical Research, (20160100), vol. 9, no. 2, pages 40 - 43, XP009189654
OPPOSITION- S.J. STOHS et al., "A Review of the Efficacy and Safety of Banaba (Lagerstroemia speciosa L.) and Corosolic Acid", Pyhtotherapy research, (20120000), vol. 26, pages 317 - 324, XP055832094
OPPOSITION- MIURA T. et al., "Management of Diabetes and Its Complications with Banaba, (Lagerstroemia speciosa L.) and Corosolic Acid", Evidence-Based Complementary Altern. Med., (20120000), XP055340944

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents